Huang Chunrong, Gao Yulian, Lin Hongxia, Fan Qinmei, Chen Ling, Feng Yun
Department of Respiratory and Critical Care Medicine, Ruijin Hospital Affiliated Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China.
Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200025, People's Republic of China.
Infect Drug Resist. 2024 Sep 3;17:3825-3837. doi: 10.2147/IDR.S475073. eCollection 2024.
To evaluate the clinical features of patients with bloodstream infection (BSI).
Totally 200 inpatients with BSI were included, clinical features of BSI inpatients between 90-day survival and 90-day mortality groups, between 30-day survival and 30-day mortality groups, between patients infected with multidrug-resistant (MDR group) and sensitive (sensitive group) were analyzed. The prognostic factors of 90-day mortality were analyzed by univariate logistic regression and multivariate logistic regression. The survival curve in bloodstream infectious patients with multidrug-resistant (MDR group) and sensitive (sensitive group) was analyzed by Kaplan-Meier analysis.
The 90-day mortality patients had significantly higher carbapenem-resistant bacterial infection and critical care unit (ICU) admission. The 90-day and 30-day mortality groups showed higher C-reactive protein (CRP) and serum creatinine (Scr) levels and lower red blood cells (RBC) and albumin (ALB) levels than their survival counterparts, respectively. Critical surgery, ICU admission and delayed antibiotic treatment were independently prognostic risk predictors for 90-day mortality in BSI patients, while critical surgery and diabetes were independently prognostic risk predictors for 90-day mortality in carbapenem-resistant BSI patients. Compared with sensitive group, MDR group showed significantly longer ICU and whole hospital stay, lower levels of lymphocytes, RBC, hemoglobin, lactate dehydrogenase and ALB, higher frequency of infection originating from the skin and skin structure. Moreover, patients in the MDR group had a significantly worse overall survival than the sensitive group.
We identified the prognostic factors of BSI and carbapenem-resistant BSI patients. Critical surgery, ICU admission, delayed antibiotic treatment or diabetes were significantly associated with the mortality of those patients. Moreover, aggressive measures to control MDR could lead to improved outcomes.
评估血流感染(BSI)患者的临床特征。
纳入200例BSI住院患者,分析90天生存组与90天死亡组、30天生存组与30天死亡组、多重耐药感染患者(MDR组)与敏感感染患者(敏感组)之间BSI住院患者的临床特征。采用单因素logistic回归和多因素logistic回归分析90天死亡率的预后因素。采用Kaplan-Meier分析对多重耐药(MDR组)和敏感(敏感组)血流感染患者的生存曲线进行分析。
90天死亡患者的碳青霉烯耐药菌感染率和入住重症监护病房(ICU)的比例显著更高。90天和30天死亡组的C反应蛋白(CRP)和血清肌酐(Scr)水平分别高于其生存对应组,而红细胞(RBC)和白蛋白(ALB)水平则低于生存对应组。重症手术、入住ICU和延迟抗生素治疗是BSI患者90天死亡率的独立预后风险预测因素,而重症手术和糖尿病是碳青霉烯耐药BSI患者90天死亡率的独立预后风险预测因素。与敏感组相比,MDR组的ICU住院时间和全院住院时间显著更长,淋巴细胞、RBC、血红蛋白、乳酸脱氢酶和ALB水平更低,皮肤及皮肤结构感染的发生率更高。此外,MDR组患者的总体生存率明显低于敏感组。
我们确定了BSI和碳青霉烯耐药BSI患者的预后因素。重症手术、入住ICU、延迟抗生素治疗或糖尿病与这些患者的死亡率显著相关。此外,积极控制多重耐药菌可改善预后。